21 results match your criteria: "University of Oxford Centre for Tropical Medicine[Affiliation]"
Wellcome Open Res
December 2024
Oxford University Clinical Research Unit, Ho Chi Minh City, Ho Chi Minh, Vietnam.
Background: Awake prone positioning (APP) may be beneficial in patients with respiratory failure who are not receiving mechanical ventilation. Randomized controlled trials of APP have been performed during peak COVID-19 periods in unvaccinated populations, with limited data on compliance or patient acceptability. We aimed to evaluate the efficacy and acceptability of APP in a lower-middle income country in an open-label randomized controlled trial using a dedicated APP implementation team and wearable continuous-monitoring devices.
View Article and Find Full Text PDFBMJ Lead
September 2024
Nuffield Department of Medicine, University of Oxford Centre for Tropical Medicine and Global Health, Oxford, UK.
Significant investments have been made in health research capacity development (HRCD) initiatives focusing on individual professionals and institutional frameworks. However, prevailing approaches often prioritise specific research projects over explicit strategies for strengthening the capacities of health research professionals (HRPs) particularly in low and middle-income countries. Despite recognition of its limitations, this implicit approach persists resulting in a lack of effective HRCD strategies.
View Article and Find Full Text PDFBMJ Glob Health
March 2024
HealthAI, Geneva, Switzerland.
Introduction: Citizen science (CS) is an emerging approach in public health to harness the collective intelligence of individuals to augment traditional scientific efforts. However, citizens' viewpoint, especially the hard-to-reach population, is lacking in current outbreak-related literature. We aim to understand the awareness, readiness and feasibility of outbreak-related CS, including digitally enabled CS, in low-income and middle-income countries.
View Article and Find Full Text PDFBMJ Glob Health
June 2023
Center for Tropical Medicine and Global Health, University of Oxford Centre for Tropical Medicine, Oxford, UK.
There was, and possibly still is, potential for COVID-19 to disrupt power inequities and contribute to positive transformation in global health research that increases equity. While there is consensus about the need to decolonise by transforming global health, and a roadmap outlining how we could approach it, there are few examples of steps that could be taken to transform the mechanics of global health research. This paper contributes lessons learnt from experiences and reflections of our diverse multinational team of researchers involved in a multicountry research project.
View Article and Find Full Text PDFBMJ Open
November 2022
Population Health Research Institute, St George's University of London, London, UK.
Objective: Contemporary data on the attainment of optimal diabetes treatment goals and the burden of diabetes complications in adult populations with type 2 diabetes in Africa are lacking. We aimed to document the current status of attainment of three key indicators of optimal diabetes care and the prevalence of five diabetes complications in adult African populations with type 2 diabetes.
Methods: We systematically searched Embase, PubMed and the Cochrane library for published studies from January 2000 to December 2020.
BMJ Glob Health
August 2022
Health Systems Collaborative, Nuffield Department of Medicine, Oxford, UK.
Attention has turned to improving the quality and safety of healthcare within health facilities to reduce avoidable mortality and morbidity. Interventions should be tested in health system environments that can support their adoption if successful. To be successful, interventions often require changes in multiple behaviours making their consequences unpredictable.
View Article and Find Full Text PDFBMJ Glob Health
August 2022
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Medicine Quality Research Group, Laboratory of Microbiology, Mahosot Hospital, Vientiane, Lao People's Democratic Republic
Objectives: Antimicrobial resistance (AMR) is a significant global health threat with substandard and falsified (SF) antibiotics being neglected contributing factors. With their relationships poorly understood, more research is needed in order to determine how interventions to reduce SF antibiotics should be ranked as priorities in national AMR action plans. We assessed the evidence available on the global prevalence of SF antibiotics, examined the quality of the evidence and discussed public health impact.
View Article and Find Full Text PDFBMJ Glob Health
August 2022
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Medicine Quality Research Group, Microbiology Laboratory, Mahosot Hospital, Vientiane, Lao People's Democratic Republic
Objective: Substandard and falsified (SF) veterinary medicines affect animal health, agricultural production and food security and will influence antimicrobial resistance (AMR) in both animals and humans. Yet, our understanding of their extent and impact is poor. We assess the available public domain evidence on the epidemiology of SF veterinary medicines, to better understand their prevalence and distribution and their public health impact on animals and humans.
View Article and Find Full Text PDFBMJ Open
July 2021
Nuffield Department of Medicine, University of Oxford Centre for Tropical Medicine and Global Health, Oxford, UK.
Objectives: A key barrier in supporting health research capacity development (HRCD) is the lack of empirical measurement of competencies to assess skills and identify gaps in research activities. An effective tool to measure HRCD in healthcare workers would help inform teams to undertake more locally led research. The objective of this systematic review is to identify tools measuring healthcare workers' individual capacities to conduct research.
View Article and Find Full Text PDFBMJ Glob Health
June 2021
Department of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
Background: Routine health information system(s) (RHIS) facilitate the collection of health data at all levels of the health system allowing estimates of disease prevalence, treatment and preventive intervention coverage, and risk factors to guide disease control strategies. This core health system pillar remains underdeveloped in many low-income and middle-income countries. Efforts to improve RHIS data coverage, quality and timeliness were launched over 10 years ago.
View Article and Find Full Text PDFBMJ Glob Health
March 2021
World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Early on in the COVID-19 pandemic, the WHO Eastern Mediterranean Regional Office recognised the importance of epidemiological modelling to forecast the progression of the COVID-19 pandemic to support decisions guiding the implementation of response measures. We established a modelling support team to facilitate the application of epidemiological modelling analyses in the Eastern Mediterranean Region (EMR) countries. Here, we present an innovative, stepwise approach to participatory modelling of the COVID-19 pandemic that engaged decision-makers and public health professionals from countries throughout all stages of the modelling process.
View Article and Find Full Text PDFBMJ Glob Health
December 2020
Centre for Mathematics, Computation and Cognition, Federal University of ABC Center of Mathematics Computing and Cognition, Santo Andre, São Paulo, Brazil.
The SARS-CoV-2 pandemic has had an unprecedented impact on multiple levels of society. Not only has the pandemic completely overwhelmed some health systems but it has also changed how scientific evidence is shared and increased the pace at which such evidence is published and consumed, by scientists, policymakers and the wider public. More significantly, the pandemic has created tremendous challenges for decision-makers, who have had to implement highly disruptive containment measures with very little empirical scientific evidence to support their decision-making process.
View Article and Find Full Text PDFBMJ Glob Health
December 2020
Centre for Tropical Medicine and Global Health, University of Oxford Centre for Tropical Medicine, Oxford, UK.
Background: The social determinants of health are a decisive yet persistently understudied area for tackling global health challenges like antimicrobial resistance (AMR). Precarity is one determinant whose importance is increasingly recognised, which we define here as 'a form of pernicious self-dependence that undermines individuals' control over their own lives and limits their ability to flexibly respond to crises'. We aimed to assess the relationship between precarity, other forms of deprivation and healthcare-seeking behaviour by asking, 'What is the impact of precarity, marginalisation and clinical presentation on healthcare-seeking behaviour?' and 'Do patients experiencing precarious livelihoods have clinically less advisable healthcare-seeking behaviour?'
Methods: We used healthcare-seeking behaviour census survey data from rural Thailand and Laos, wherein five rural communities were surveyed two times over a period of 3 months (2-month recall period).
JAC Antimicrob Resist
September 2020
Oxford University Clinical Research Unit, Hanoi Unit, Hanoi, Vietnam.
Objectives: To review community-level consumption of antibiotics in rural Vietnam, according to the WHO Access, Watch, Reserve (AWaRe) classification of 2019, and identify factors associated with the choice of these antibiotics.
Methods: In this cross-sectional study, data on antibiotic purchases were collected through a customer exit survey of 20 community antibiotic suppliers in Ba Vi District, Hanoi, between September 2017 and July 2018. Antibiotic consumption was estimated through the number of antibiotic encounters, the number of DDDs supplied and the number of treatment days (DOTs) with antibiotics, and analysed according to the AWaRe classification.
Arch Dis Child
February 2021
Clinical Research Department, KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Background: Detection of meningitis is essential to optimise the duration and choice of antimicrobial agents to limit mortality and sequelae. In low and middle-income countries most health facilities lack laboratory capacity and rely on clinical features to empirically treat meningitis.
Objective: We conducted a diagnostic validation study to investigate the performance of clinical features (fever, convulsions, irritability, bulging fontanel and temperature ≥39°C) and WHO-recommended signs (drowsiness, lethargy, unconsciousness, convulsions, bulging fontanel, irritability or a high-pitched cry) in discriminating meningitis in young infants.
BMJ Glob Health
July 2020
Nuffield Department of Medicine, University of Oxford Centre for Tropical Medicine and Global Health, Oxford, UK
Introduction: In March 2020, the WHO released a Global Research Roadmap in an effort to coordinate and accelerate the global research response to combat COVID-19 based on deliberations of 400 experts across the world. Three months on, the disease and our understanding have both evolved significantly. As we now tackle a pandemic in very different contexts and with increased knowledge, we sought to build on the work of the WHO to gain a more current and global perspective on these initial priorities.
View Article and Find Full Text PDFBMJ Open
July 2020
Mahidol Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.
Objectives: Neonatal mortality remains persistently high in low-income and middle-income countries. In Cambodia, there is a paucity of data on the perception of neonatal health and care-seeking behaviours at the community level. This study aimed to identify influencers of neonatal health and healthcare-seeking behaviour in a rural Cambodian province.
View Article and Find Full Text PDFBMJ Glob Health
January 2021
Center for Tropical Medicine and Global Health, University of Oxford Centre for Tropical Medicine, Oxford, UK.
There are global calls for research to support health system strengthening in low-income and middle-income countries (LMICs). To examine the nature and magnitude of gaps in access and quality of inpatient neonatal care provided to a largely poor urban population, we combined multiple epidemiological and health services methodologies. Conducting this work and generating findings was made possible through extensive formal and informal stakeholder engagement linked to flexibility in the research approach while keeping overall goals in mind.
View Article and Find Full Text PDFBMJ Open
August 2019
Center for Tropical Medicine and Global Health, University of Oxford Centre for Tropical Medicine, Oxford, UK.
Introduction: Low-income and middle-income countries (LMICs) are crucial in the global response to antimicrobial resistance (AMR), but diverse health systems, healthcare practices and cultural conceptions of medicine can complicate global education and awareness-raising campaigns. Social research can help understand LMIC contexts but remains under-represented in AMR research.
Objective: To (1) Describe antibiotic-related knowledge, attitudes and practices of the general population in two LMICs.
BMC Anesthesiol
July 2016
Department of Medicine and Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, Canada.
Background: The Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging respiratory pathogen with a high mortality rate and no specific treatments available to date. The purpose of this study was to determine the feasibility of conducting a randomized controlled trial (RCT) of convalescent plasma therapy for MERS-CoV-infected patients by using MERS-CoV-specific convalescent plasma obtained from previously recovered patients.
Methods: A survey was adapted from validated questionnaire originally aimed to measure network capacities and capabilities within the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC).
Springerplus
November 2015
Department of Medicine and Institute of Health Policy Management and Evaluation, AMR Infection Control and Publications AIP/PED/HSE/HQ, University of Toronto, Toronto, Canada ; Department of Critical Care Medicine and Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada.
As of September 30, 2015, a total of 1589 laboratory-confirmed cases of infection with the Middle East respiratory syndrome coronavirus (MERS-CoV) have been reported to the World Health Organization (WHO). At present there is no effective specific therapy against MERS-CoV. The use of convalescent plasma (CP) has been suggested as a potential therapy based on existing evidence from other viral infections.
View Article and Find Full Text PDF